ERNEST MARIO Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ERNEST MARIO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ERNEST MARIO. ERNEST MARIO is Director in BOSTON SCIENTIFIC CORP ($BSX) and in CELGENE CORP /DE/ ($CELG) and Director in CELGENE CORP /DE/ ($CELG) and Director in XENOPORT INC ($XNPT) and Director in CHIMERIX INC ($CMRX) and Director in Tonix Pharmaceuticals Holding Corp. ($TNXP) and Director in Capnia, Inc. ($CAPN) and Director in Kindred Biosciences, Inc. ($KIN) and Director in EYENOVIA, INC. ($EYEN).
Latest Insider Trading Transactions of ERNEST MARIO
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BSX, CELG, CMRX, EYEN, KIN, SLNO, TNXP, XNPT
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 04 2021 | SLNO | SOLENO THERAPEUTIC ... | MARIO ERNEST | Director | Grant | A | 1.21 | 16,529 | 20,000 | 1,176,416 | 1.2 M to 1.2 M (+1.43 %) |
Feb 02 2021 | SLNO | SOLENO THERAPEUTIC ... | MARIO ERNEST | Director | Grant | A | 0.00 | 8,928 | 0 | 1,157,804 | 1.1 M to 1.2 M (+0.78 %) |
Jan 22 2021 | KIN | Kindred Bioscience ... | MARIO ERNEST | Director | Option Exercise | A | 4.44 | 49,000 | 217,560 | 49,000 | |
Jan 19 2021 | EYEN | EYENOVIA, INC. | MARIO ERNEST | Director | Option Exercise | X | 2.27 | 41,216 | 93,560 | 0 | |
Jan 19 2021 | EYEN | EYENOVIA, INC. | MARIO ERNEST | Director | Buy | X | 2.27 | 41,216 | 93,560 | 375,743 | 334.5 K to 375.7 K (+12.32 %) |
Jan 12 2021 | SLNO | SOLENO THERAPEUTIC ... | MARIO ERNEST | Director | Option Exercise | A | 2.24 | 40,000 | 89,600 | 40,000 | |
Sep 15 2020 | EYEN | EYENOVIA, INC. | MARIO ERNEST | Director | Option Exercise | A | 3.43 | 9,820 | 33,683 | 9,820 | |
Sep 15 2020 | EYEN | EYENOVIA, INC. | MARIO ERNEST | Director | Grant | A | 0.00 | 7,288 | 0 | 334,527 | 327.2 K to 334.5 K (+2.23 %) |
Aug 03 2020 | SLNO | SOLENO THERAPEUTIC ... | MARIO ERNEST | Director | Grant | A | 1.72 | 10,174 | 17,499 | 10,174 | 0 to 10.2 K |
May 20 2020 | SLNO | SOLENO THERAPEUTIC ... | MARIO ERNEST | Director | Option Exercise | A | 3.41 | 9,530 | 32,497 | 9,530 | |
May 04 2020 | SLNO | SOLENO THERAPEUTIC ... | MARIO ERNEST | Director | Grant | A | 3.05 | 5,738 | 17,501 | 5,738 | 0 to 5.7 K |
May 04 2020 | SLNO | SOLENO THERAPEUTIC ... | MARIO ERNEST | Director | Grant | A | 3.05 | 5,738 | 17,501 | 5,738 | 0 to 5.7 K |
Mar 26 2020 | EYEN | EYENOVIA, INC. | MARIO ERNEST | Director | Option Exercise | P | 2.72 | 61,823 | 168,406 | 61,823 | |
Mar 26 2020 | EYEN | EYENOVIA, INC. | MARIO ERNEST | Director | Option Exercise | P | 2.27 | 41,216 | 93,560 | 41,216 | |
Mar 26 2020 | EYEN | EYENOVIA, INC. | MARIO ERNEST | Director | Buy | P | 2.27 | 82,431 | 187,118 | 327,239 | 244.8 K to 327.2 K (+33.67 %) |
Jan 24 2020 | SLNO | SOLENO THERAPEUTIC ... | MARIO ERNEST | Director | Grant | A | 3.35 | 10,448 | 35,001 | 10,448 | 0 to 10.4 K |
Jan 22 2020 | KIN | Kindred Bioscience ... | MARIO ERNEST | Director | Option Exercise | A | 9.84 | 49,000 | 482,160 | 49,000 | |
Nov 22 2019 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Option Exercise | D | 0.00 | 4,756 | 0 | 0 | ||
Nov 22 2019 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Option Exercise | D | 0.00 | 970 | 0 | 0 | ||
Nov 22 2019 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Option Exercise | D | 0.00 | 300 | 0 | 0 | ||
Nov 22 2019 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Option Exercise | D | 77.38 | 13,266 | 1,026,523 | 0 | ||
Nov 22 2019 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Option Exercise | D | 121.04 | 10,500 | 1,270,920 | 0 | ||
Nov 22 2019 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Option Exercise | D | 99.98 | 11,000 | 1,099,780 | 0 | ||
Nov 22 2019 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Option Exercise | D | 112.16 | 10,000 | 1,121,600 | 0 | ||
Nov 22 2019 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Option Exercise | D | 88.50 | 20,700 | 1,831,950 | 0 | ||
Nov 22 2019 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Sell | D | 0.00 | 4,908 | 0 | 0 | 4.9 K to 0 (-100.00 %) | |
Nov 22 2019 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Sell | D | 0.00 | 62,884 | 0 | 0 | 62.9 K to 0 (-100.00 %) | |
Aug 20 2019 | EYEN | EYENOVIA, INC. | MARIO ERNEST | Director | Option Exercise | A | 3.11 | 9,057 | 28,167 | 9,057 | |
Aug 20 2019 | EYEN | EYENOVIA, INC. | MARIO ERNEST | Director | Grant | A | 0.00 | 8,038 | 0 | 280,779 | 272.7 K to 280.8 K (+2.95 %) |
Jul 15 2019 | EYEN | EYENOVIA, INC. | MARIO ERNEST | Director | Buy | P | 2.78 | 35,971 | 99,999 | 272,741 | 236.8 K to 272.7 K (+15.19 %) |
Jun 17 2019 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Option Exercise | M | 0.00 | 375 | 0 | 0 | ||
Jun 17 2019 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Option Exercise | M | 0.00 | 300 | 0 | 300 | ||
Jun 17 2019 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Option Exercise | M | 0.00 | 484 | 0 | 970 | ||
Jun 17 2019 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Buy | M | 0.00 | 375 | 0 | 62,884 | 62.5 K to 62.9 K (+0.60 %) | |
Jun 17 2019 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Buy | M | 0.00 | 300 | 0 | 62,509 | 62.2 K to 62.5 K (+0.48 %) | |
Jun 17 2019 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Buy | M | 0.00 | 484 | 0 | 62,209 | 61.7 K to 62.2 K (+0.78 %) | |
Jun 12 2019 | SLNO | SOLENO THERAPEUTIC ... | MARIO ERNEST | Director | Option Exercise | A | 2.50 | 13,000 | 32,500 | 13,000 | |
Jun 05 2019 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Option Exercise | A | 0.00 | 4,756 | 0 | 4,756 | ||
May 21 2019 | EYEN | EYENOVIA, INC. | MARIO ERNEST | Director | Buy | P | 10.00 | 90,000 | 900,000 | 236,770 | 146.8 K to 236.8 K (+61.32 %) |
Mar 07 2019 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Buy | J | 85.97 | 2,908 | 250,001 | 4,908 | 2 K to 4.9 K (+145.40 %) | |
Mar 07 2019 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Sell | J | 85.97 | 2,908 | 250,001 | 55,005 | 57.9 K to 55 K (-5.02 %) | |
Feb 05 2019 | KIN | Kindred Bioscience ... | MARIO ERNEST | Director | Option Exercise | A | 9.91 | 49,000 | 485,590 | 49,000 | |
Dec 20 2018 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Option Exercise | M | 59.06 | 8,600 | 507,873 | 0 | ||
Dec 20 2018 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Buy | M | 59.06 | 8,600 | 507,873 | 63,013 | 54.4 K to 63 K (+15.81 %) | |
Nov 28 2018 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Option Exercise | M | 59.06 | 10,000 | 590,550 | 8,600 | ||
Nov 28 2018 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Buy | M | 59.06 | 10,000 | 590,550 | 54,413 | 44.4 K to 54.4 K (+22.52 %) | |
Oct 31 2018 | KIN | Kindred Bioscience ... | MARIO ERNEST | Director | Option Exercise | M | 3.45 | 44,000 | 151,800 | 0 | |
Oct 31 2018 | KIN | Kindred Bioscience ... | MARIO ERNEST | Director | Option Exercise | M | 1.37 | 833 | 1,141 | 0 | |
Oct 31 2018 | KIN | Kindred Bioscience ... | MARIO ERNEST | Director | Buy | M | 3.45 | 44,000 | 151,800 | 169,000 | 125 K to 169 K (+35.20 %) |
Oct 31 2018 | KIN | Kindred Bioscience ... | MARIO ERNEST | Director | Buy | M | 1.37 | 833 | 1,141 | 125,000 | 124.2 K to 125 K (+0.67 %) |
Aug 13 2018 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Sell | S | 92.32 | 12,000 | 1,107,888 | 44,413 | 56.4 K to 44.4 K (-21.27 %) | |
Jul 26 2018 | EYEN | EYENOVIA, INC. | MARIO ERNEST | Director | Option Exercise | A | 6.20 | 4,465 | 27,683 | 4,465 | |
Jul 26 2018 | EYEN | EYENOVIA, INC. | MARIO ERNEST | Director | Grant | A | 0.00 | 4,033 | 0 | 146,770 | 142.7 K to 146.8 K (+2.83 %) |
Jun 27 2018 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Buy | P | 4.48 | 16,500 | 73,920 | 50,000 | 33.5 K to 50 K (+49.25 %) |
Jun 26 2018 | KIN | Kindred Bioscience ... | MARIO ERNEST | Director | Option Exercise | A | 11.00 | 10,000 | 110,000 | 10,000 | |
Jun 18 2018 | SLNO | SOLENO THERAPEUTIC ... | MARIO ERNEST | Director | Option Exercise | A | 2.04 | 15,931 | 32,499 | 15,931 | |
Jun 18 2018 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Option Exercise | M | 0.00 | 334 | 0 | 0 | ||
Jun 18 2018 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Buy | M | 0.00 | 334 | 0 | 56,413 | 56.1 K to 56.4 K (+0.60 %) | |
Jun 15 2018 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Option Exercise | M | 0.00 | 375 | 0 | 375 | ||
Jun 15 2018 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Option Exercise | M | 0.00 | 300 | 0 | 600 | ||
Jun 15 2018 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Option Exercise | A | 77.38 | 13,266 | 1,026,523 | 13,266 | ||
Jun 15 2018 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Option Exercise | A | 0.00 | 1,454 | 0 | 1,454 | ||
Jun 15 2018 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Buy | M | 0.00 | 375 | 0 | 56,079 | 55.7 K to 56.1 K (+0.67 %) | |
Jun 15 2018 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Buy | M | 0.00 | 300 | 0 | 55,704 | 55.4 K to 55.7 K (+0.54 %) | |
Jun 13 2018 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Option Exercise | A | 4.25 | 20,000 | 85,000 | 20,000 | |
Jun 13 2018 | SLNO | SOLENO THERAPEUTIC ... | MARIO ERNEST | Director | Grant | A | 2.04 | 3,606 | 7,356 | 475,324 | 471.7 K to 475.3 K (+0.76 %) |
Jun 13 2018 | SLNO | SOLENO THERAPEUTIC ... | MARIO ERNEST | Director | Grant | A | 2.04 | 500 | 1,020 | 471,718 | 471.2 K to 471.7 K (+0.11 %) |
Jun 13 2018 | SLNO | SOLENO THERAPEUTIC ... | MARIO ERNEST | Director | Grant | A | 2.05 | 4,980 | 10,209 | 471,218 | 466.2 K to 471.2 K (+1.07 %) |
Jun 11 2018 | SLNO | SOLENO THERAPEUTIC ... | MARIO ERNEST | Director | Grant | A | 2.04 | 14,803 | 30,257 | 466,238 | 451.4 K to 466.2 K (+3.28 %) |
Jun 11 2018 | SLNO | SOLENO THERAPEUTIC ... | MARIO ERNEST | Director | Grant | A | 2.00 | 4,611 | 9,234 | 451,435 | 446.8 K to 451.4 K (+1.03 %) |
Jun 07 2018 | SLNO | SOLENO THERAPEUTIC ... | MARIO ERNEST | Director | Grant | A | 2.05 | 1,200 | 2,460 | 446,824 | 445.6 K to 446.8 K (+0.27 %) |
Jun 04 2018 | SLNO | SOLENO THERAPEUTIC ... | MARIO ERNEST | Director | Grant | A | 2.05 | 1,300 | 2,665 | 445,624 | 444.3 K to 445.6 K (+0.29 %) |
Jun 04 2018 | SLNO | SOLENO THERAPEUTIC ... | MARIO ERNEST | Director | Grant | A | 2.05 | 500 | 1,025 | 444,324 | 443.8 K to 444.3 K (+0.11 %) |
May 29 2018 | SLNO | SOLENO THERAPEUTIC ... | MARIO ERNEST | Director | Grant | A | 2.01 | 500 | 1,005 | 443,824 | 443.3 K to 443.8 K (+0.11 %) |
May 29 2018 | SLNO | SOLENO THERAPEUTIC ... | MARIO ERNEST | Director | Grant | A | 2.05 | 5,000 | 10,250 | 443,324 | 438.3 K to 443.3 K (+1.14 %) |
May 22 2018 | SLNO | SOLENO THERAPEUTIC ... | MARIO ERNEST | Director | Grant | A | 1.94 | 5,000 | 9,720 | 438,324 | 433.3 K to 438.3 K (+1.15 %) |
May 22 2018 | SLNO | SOLENO THERAPEUTIC ... | MARIO ERNEST | Director | Grant | A | 1.95 | 25,000 | 48,750 | 433,324 | 408.3 K to 433.3 K (+6.12 %) |
May 21 2018 | SLNO | SOLENO THERAPEUTIC ... | MARIO ERNEST | Director | Grant | A | 1.90 | 25,000 | 47,500 | 408,324 | 383.3 K to 408.3 K (+6.52 %) |
May 21 2018 | CMRX | CHIMERIX INC | MARIO ERNEST | Director | Sell | S | 4.81 | 15,000 | 72,143 | 108,167 | 123.2 K to 108.2 K (-12.18 %) |
May 21 2018 | CMRX | CHIMERIX INC | MARIO ERNEST | Director | Sell | S | 4.80 | 30,000 | 143,931 | 123,167 | 153.2 K to 123.2 K (-19.59 %) |
May 17 2018 | CMRX | CHIMERIX INC | MARIO ERNEST | Director | Sell | S | 4.79 | 30,000 | 143,808 | 153,167 | 183.2 K to 153.2 K (-16.38 %) |
May 16 2018 | CMRX | CHIMERIX INC | MARIO ERNEST | Director | Sell | S | 4.69 | 30,000 | 140,808 | 183,167 | 213.2 K to 183.2 K (-14.07 %) |
May 16 2018 | CMRX | CHIMERIX INC | MARIO ERNEST | Director | Sell | S | 4.69 | 30,000 | 140,808 | 183,167 | 213.2 K to 183.2 K (-14.07 %) |
May 15 2018 | CMRX | CHIMERIX INC | MARIO ERNEST | Director | Sell | S | 4.67 | 22,553 | 105,232 | 213,167 | 235.7 K to 213.2 K (-9.57 %) |
May 15 2018 | CMRX | CHIMERIX INC | MARIO ERNEST | Director | Sell | S | 4.63 | 22,857 | 105,766 | 235,720 | 258.6 K to 235.7 K (-8.84 %) |
May 15 2018 | CMRX | CHIMERIX INC | MARIO ERNEST | Director | Sell | S | 4.57 | 7,143 | 32,614 | 258,577 | 265.7 K to 258.6 K (-2.69 %) |
May 11 2018 | CMRX | CHIMERIX INC | MARIO ERNEST | Director | Sell | S | 4.60 | 2,815 | 12,949 | 265,720 | 268.5 K to 265.7 K (-1.05 %) |
Apr 24 2018 | KIN | Kindred Bioscience ... | MARIO ERNEST | Director | Option Exercise | A | 9.65 | 44,603 | 430,419 | 44,603 | |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Option Exercise | M | 0.00 | 600 | 0 | 0 | |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Option Exercise | M | 0.00 | 750 | 0 | 0 | |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Option Exercise | M | 0.00 | 750 | 0 | 0 | |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Buy | M | 0.00 | 600 | 0 | 26,648 | 26 K to 26.6 K (+2.30 %) |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Buy | M | 0.00 | 750 | 0 | 63,822 | 63.1 K to 63.8 K (+1.19 %) |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Buy | M | 0.00 | 750 | 0 | 64,572 | 63.8 K to 64.6 K (+1.18 %) |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Gift | G | 0.00 | 10,000 | 0 | 33,500 | 23.5 K to 33.5 K (+42.55 %) |
Mar 09 2018 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Gift | G | 0.00 | 10,000 | 0 | 0 | 10 K to 0 (-100.00 %) |
Feb 26 2018 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Director | Sell | S | 94.49 | 13,370 | 1,263,298 | 55,404 | 68.8 K to 55.4 K (-19.44 %) |
Feb 26 2018 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Director | Gift | G | 0.00 | 2,250 | 0 | 324 | 2.6 K to 324 (-87.41 %) |
Feb 26 2018 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Director | Gift | G | 0.00 | 2,250 | 0 | 68,774 | 71 K to 68.8 K (-3.17 %) |
Feb 07 2018 | CAPN | SOLENO THERAPEUTIC ... | MARIO ERNEST | Director | Grant | A | 1.73 | 8,689 | 15,000 | 704,352 | 695.7 K to 704.4 K (+1.25 %) |
Dec 22 2017 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Sell | S | 3.46 | 5,000 | 17,300 | 23,500 | 28.5 K to 23.5 K (-17.54 %) |
Dec 22 2017 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Sell | S | 3.44 | 8,965 | 30,840 | 28,500 | 37.5 K to 28.5 K (-23.93 %) |
Dec 22 2017 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Sell | S | 3.51 | 6,035 | 21,183 | 37,465 | 43.5 K to 37.5 K (-13.87 %) |
Dec 22 2017 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Sell | S | 3.57 | 10,000 | 35,700 | 43,500 | 53.5 K to 43.5 K (-18.69 %) |
Dec 22 2017 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Sell | S | 3.55 | 5,000 | 17,750 | 53,500 | 58.5 K to 53.5 K (-8.55 %) |
Dec 22 2017 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Sell | S | 3.58 | 1,967 | 7,042 | 55,467 | 57.4 K to 55.5 K (-3.42 %) |
Nov 01 2017 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Director | Option Exercise | M | 31.80 | 13,600 | 432,412 | 0 | |
Nov 01 2017 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Director | Buy | M | 31.80 | 13,600 | 432,412 | 71,024 | 57.4 K to 71 K (+23.68 %) |
Oct 04 2017 | CAPN | SOLENO THERAPEUTIC ... | MARIO ERNEST | Director | Grant | A | 0.52 | 28,846 | 15,000 | 1,873,174 | 1.8 M to 1.9 M (+1.56 %) |
Aug 31 2017 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Director | Sell | S | 121.24 | 12,000 | 1,454,880 | 57,424 | 69.4 K to 57.4 K (-17.29 %) |
Aug 14 2017 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Director | Sell | S | 130.52 | 18,506 | 2,415,403 | 69,424 | 87.9 K to 69.4 K (-21.05 %) |
Jul 17 2017 | CAPN | SOLENO THERAPEUTIC ... | MARIO ERNEST | Director | Grant | A | 0.61 | 24,590 | 15,000 | 1,844,328 | 1.8 M to 1.8 M (+1.35 %) |
Jul 05 2017 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Director | Option Exercise | M | 0.00 | 734 | 0 | 0 | |
Jul 05 2017 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Director | Buy | M | 0.00 | 734 | 0 | 87,930 | 87.2 K to 87.9 K (+0.84 %) |
Jun 30 2017 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Sell | S | 4.28 | 6,105 | 26,117 | 5,895 | 12 K to 5.9 K (-50.87 %) |
Jun 29 2017 | CMRX | CHIMERIX INC | MARIO ERNEST | Director | Option Exercise | A | 5.53 | 6,341 | 35,066 | 6,341 | |
Jun 29 2017 | CMRX | CHIMERIX INC | MARIO ERNEST | Director | Option Exercise | A | 5.53 | 21,000 | 116,130 | 21,000 | |
Jun 21 2017 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Option Exercise | A | 4.18 | 20,000 | 83,600 | 20,000 | |
Jun 20 2017 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Director | Option Exercise | M | 0.00 | 333 | 0 | 334 | |
Jun 20 2017 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Director | Buy | M | 0.00 | 333 | 0 | 87,196 | 86.9 K to 87.2 K (+0.38 %) |
Jun 16 2017 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Director | Option Exercise | M | 0.00 | 375 | 0 | 750 | |
Jun 16 2017 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Director | Option Exercise | A | 0.00 | 900 | 0 | 900 | |
Jun 16 2017 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Director | Option Exercise | A | 121.04 | 10,500 | 1,270,920 | 10,500 | |
Jun 16 2017 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Director | Buy | M | 0.00 | 375 | 0 | 86,863 | 86.5 K to 86.9 K (+0.43 %) |
Jun 16 2017 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Director | Gift | G | 0.00 | 3,570 | 0 | 86,488 | 90.1 K to 86.5 K (-3.96 %) |
May 09 2017 | CAPN | Capnia, Inc. | MARIO ERNEST | Director | Option Exercise | A | 0.72 | 45,139 | 32,500 | 45,139 | |
Apr 13 2017 | CAPN | Capnia, Inc. | MARIO ERNEST | Director | Grant | A | 0.63 | 23,809 | 15,000 | 1,819,738 | 1.8 M to 1.8 M (+1.33 %) |
Apr 13 2017 | CAPN | Capnia, Inc. | MARIO ERNEST | Director | Grant | A | 0.90 | 16,667 | 15,000 | 1,795,929 | 1.8 M to 1.8 M (+0.94 %) |
Dec 29 2016 | CMRX | CHIMERIX INC | MARIO ERNEST | Director | Sell | S | 4.52 | 20,291 | 91,634 | 268,535 | 288.8 K to 268.5 K (-7.03 %) |
Dec 29 2016 | CMRX | CHIMERIX INC | MARIO ERNEST | Director | Sell | S | 4.67 | 4,000 | 18,683 | 288,826 | 292.8 K to 288.8 K (-1.37 %) |
Dec 29 2016 | CMRX | CHIMERIX INC | MARIO ERNEST | Director | Sell | S | 4.65 | 3,636 | 16,907 | 292,826 | 296.5 K to 292.8 K (-1.23 %) |
Dec 29 2016 | CMRX | CHIMERIX INC | MARIO ERNEST | Director | Sell | S | 4.68 | 72,073 | 337,143 | 296,462 | 368.5 K to 296.5 K (-19.56 %) |
Nov 28 2016 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Buy | P | 0.41 | 120,000 | 48,600 | 120,000 | 0 to 120 K |
Oct 31 2016 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Option Exercise | P | 0.63 | 100,000 | 63,000 | 100,000 | |
Oct 31 2016 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Buy | P | 0.00 | 100,000 | 0 | 630,724 | 530.7 K to 630.7 K (+18.84 %) |
Oct 11 2016 | CAPN | Capnia, Inc. | MARIO ERNEST | Director | Grant | A | 0.00 | 15,625 | 0 | 1,779,262 | 1.8 M to 1.8 M (+0.89 %) |
Sep 26 2016 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Director | Sell | S | 109.42 | 15,000 | 1,641,300 | 90,058 | 105.1 K to 90.1 K (-14.28 %) |
Sep 14 2016 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Buy | P | 0.79 | 100,000 | 79,180 | 530,724 | 430.7 K to 530.7 K (+23.22 %) |
Aug 19 2016 | CAPN | Capnia, Inc. | MARIO ERNEST | Director | Buy | P | 0.99 | 25,000 | 24,750 | 1,763,637 | 1.7 M to 1.8 M (+1.44 %) |
Jul 05 2016 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Director | Option Exercise | M | 0.00 | 733 | 0 | 734 | |
Jul 05 2016 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Director | Buy | M | 0.00 | 733 | 0 | 105,058 | 104.3 K to 105.1 K (+0.70 %) |
Jul 05 2016 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Director | Option Exercise | M | 0.00 | 733 | 0 | 734 | |
Jul 05 2016 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Director | Option Exercise | M | 0.00 | 733 | 0 | 734 | |
Jul 05 2016 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Director | Buy | M | 0.00 | 733 | 0 | 105,058 | 104.3 K to 105.1 K (+0.70 %) |
Jul 05 2016 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Director | Buy | M | 0.00 | 733 | 0 | 105,058 | 104.3 K to 105.1 K (+0.70 %) |
Jun 28 2016 | CMRX | CHIMERIX INC | MARIO ERNEST | Director | Option Exercise | A | 3.73 | 9,634 | 35,935 | 9,634 | |
Jun 28 2016 | CMRX | CHIMERIX INC | MARIO ERNEST | Director | Option Exercise | A | 3.73 | 9,000 | 33,570 | 9,000 | |
Jun 28 2016 | CMRX | CHIMERIX INC | MARIO ERNEST | Director | Buy | P | 3.70 | 50,000 | 184,845 | 381,440 | 331.4 K to 381.4 K (+15.09 %) |
Jun 21 2016 | TNXP | Tonix Pharmaceutic ... | MARIO ERNEST | Director | Buy | P | 2.00 | 50,000 | 100,000 | 430,724 | 380.7 K to 430.7 K (+13.13 %) |
Jun 17 2016 | CELG | CELGENE CORP /DE/ | MARIO ERNEST | Director | Option Exercise | M | 0.00 | 333 | 0 | 667 |